BehaveNet^®
Clinical Capsule™

Join Our Mailing List

For Email Newsletters you can trust

Follow updates to BehaveNet with Twitter

drug: duloxetine

Clinical class	antidepressant
Action	selective serotonin norepinephrine reuptake inhibitor
Chemical class	thiophenepropanamine
CSA schedule	none
DEA number	none
Routes of administration	oral
Associated with (substance-related)	disorders: none
Availability	prescription

MEDLINEplus^® Drug Information

U.S. Preparations:

Cymbalta^® (Lilly) FDA approved for treatment of:
8.3.2004 Major Depressive Disorder
9.3.2004 pain associated with diabetic peripheral neuropathy
2.23.2007 Generalized Anxiety Disorder
6.13.2008 fibromyalgia
U.S. Prescribing information

http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2009 BehaveNet®